Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Apple (AAPL) PT Raised to $195 at Canaccord Genuity
-
Corindus to Present at Upcoming Investor Conferences
-
UPDATE: Canaccord Genuity Downgrades Q2 Holdings (QTWO) to Hold
-
Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Viveve to Present at November Investor Conferences
-
Castle Biosciences to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum
-
REVA to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
-
OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
-
OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
-
OraSure Technologies (OSUR) PT Lowered to $19 at Canaccord Genuity
-
Envision Healthcare shares plunge after 'alarming' forecast
-
Altair Engineering (ALTR) IPO Opens Up 31%
-
Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017
-
Helius Medical Technologies to Present at the Canaccord Genuity Medical Technologies and Diagnostics Conference on November 9, 2017
-
Canaccord Genuity Starts VBI Vaccines (VBIV) at Buy
-
Abaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference, the Canaccord Genuity Medical Technologies & Diagnostics Form 2017 and the Stifel 2017 Healthcare Conference
-
Canaccord Genuity Downgrades Under Armour, Inc. (UAA) to Sell
-
Altair Engineering (ALTR) IPO Prices at $13
-
3D Systems (DDD) PT Lowered to $11 at Canaccord Genuity
-
Altair Engineering Inc. Announces Pricing of Initial Public Offering
-
Sequans Communications (SQNS) IoT Growth Opportunity Remains On Track - Canaccord
-
Patriot One Technologies Inc. Announces Closing of $11.5 Million Bought Deal Offering
-
Cerus to Present at Two Upcoming Conferences
-
VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares
-
Roper Industries (ROP) PT Raised to $260 at Canaccord Genuity
-
Cognex (CGNX) PT Raised to $120 at Canaccord Genuity
-
Senseonics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Chi-Med Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately US$301.3 Million on the Nasdaq Global Select Market
-
Merit Medical to Participate at Three Conferences
-
VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9 Million
-
Faro Technologies (FARO) PT Raised to $52 at Canaccord Genuity
-
Canaccord Genuity Downgrades Pacira Pharmaceuticals (PCRX) to Hold
-
Granite Construction (GVA) PT Raised to $75 at Canaccord Genuity
-
Puma Exploration Welcomes Denis Amoroso as Strategic Adviser to the board
-
Stryker (SYK) PT Raised to $162 at Canaccord Genuity on Q3 Report; 'Making it Look Easy'
-
Celgene (CELG) PT Lowered to $140 at Canaccord Genuity
-
Chi-Med Announces the Full Exercise of Underwriters' Over-allotment Option
-
Intel (INTC) PT Raised to $41 at Canaccord Genuity
-
Amazon.com (AMZN) PT Raised to $1,250 at Canaccord Genuity
-
Microsoft (MSFT) PT Raised to $94 at Canaccord Genuity
-
Canaccord Genuity Starts Alder Biopharm (ALDR) at Buy
-
Canaccord Genuity Starts Voyager Therapeutics (VYGR) at Buy
-
Canaccord Genuity Starts Biogen (BIIB) at Hold, 'Headwinds On MS Core Give us Pause'
-
Profound Medical Corp. to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Profound Medical Corp. to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Canaccord Genuity Starts AveXis (AVXS) at Hold
-
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum
-
IRIDEX to Present at Upcoming Investor Conferences
-
Boeing (BA) PT Raised to $250 at Canaccord Genuity on 3Q Report; 'Impressive' Free Cash Flow
-
VBI Vaccines (VBIV) Prices Common Stock Offerings at $3.05/Share

